Therefore, this study aimed to investigate the existence of miRNAs upstream of the m7G-modified methyltransferase complex RNMT/FAM103A1 and to identify new prognostic markers and immunotherapy drug targets in BC. This evidence concerns the gene RNMT and breast cancer.